Prelude Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-34,000
| Closed | -$74K | – | 2054 |
|
|
2021
Q3 | $74K | Hold |
34,000
| – | – | ﹤0.01% | 1172 |
|
|
2021
Q2 | $93K | Hold |
34,000
| – | – | ﹤0.01% | 1211 |
|
|
2021
Q1 | $89K | Hold |
34,000
| – | – | ﹤0.01% | 1025 |
|
|
2020
Q4 | $95K | Hold |
34,000
| – | – | ﹤0.01% | 718 |
|
|
2020
Q3 | $157K | Buy |
34,000
+16,100
| +90% | +$74.3K | 0.01% | 565 |
|
|
2020
Q2 | $50K | Buy |
+17,900
| New | +$50K | ﹤0.01% | 805 |
|
|
2017
Q4 | – | Sell |
-12
| Closed | -$1K | – | 1671 |
|
|
2017
Q3 | $1K | Sell |
12
-2,166
| -99% | -$181K | ﹤0.01% | 1440 |
|
|
2017
Q2 | $404K | Hold |
2,178
| – | – | 0.04% | 330 |
|
|
2017
Q1 | $260K | Buy |
2,178
+1,363
| +167% | +$163K | 0.02% | 435 |
|
|
2016
Q4 | $81K | Buy |
+815
| New | +$81K | 0.01% | 856 |
|